ANIARA, YOUR DRIVING SOURCE:
FOR CELLULAR TOXICOLOGY SCREENING PRODUCTS
Aniara ... The new exploration company within the Cytotoxicity and Mutagenicity field
Aniara Corporation, in partnership with Xenometrix by Endotell Gmbh, an international Swiss leader in the field of Cytotoxicity and Mutagenicity testing, now offers a full line of test systems designed to help improve the effectiveness of drug discovery and development through lead optimization to the North, Central, and South American, and Nordic European markets.
Our goal and philosophy is to provide high quality products in a cost-effective manner. Our vision is to increase the number of efficient alternative Mutagenicity and Cytotoxicity test systems throughout the market.
Xenometrix by Endotell GmbH strongly focuses on the development of new, alternative mutagenicity assays and cytotoxicity that will help reduce hands-on time, reduce the amount of compound used for testing, decrease plastic waste, and lessen the cost of doing business. These kits can also be automated on robotics systems for mass screenings.
The Ames Test Kits
The Ames MPF™ 98/100/1535/1537 Assay - Combination Kit
As genetic toxicity testing has moved towards the earlier stages of drug discovery, in order to identify genotoxic liabilities of new compounds in the pipeline, The Ames MPF combination Assay provides novel mutagenicity testing in liquid microplate format, utilizing S.typhimurium TA98, TA100, TA1535 and TA1537.
The Ames MPF™ 98/100
As genetic toxicity testing has moved towards the earlier stages of drug discovery, in order to identify genotoxic liabilities of new compounds in the pipeline, The Ames MPF 98/100 Assay provides novel mutagenicity testing in liquid microplate format, utilizing S. typhimurium TA98 and TA 100.
The Ames MPF 98™ Assay As genetic toxicity testing has moved towards the earlier stages of drug discovery, in order to identify genotoxic liabilities of new compounds in the pipeline, The Ames MPF 98 Assay provides novel mutagenicity testing in liquid microplate format, utilizing S. typhimurium TA98.
The Ames MPF 100™ Assay As genetic toxicity testing has moved towards the earlier stages of drug discovery, in order to identify genotoxic liabilities of new compounds in the pipeline, The Ames MPF 100 Assay provides novel mutagenicity testing in liquid microplate format, utilizing S. typhimurium TA 100.
The Ames MPF 1535™ Assay As genetic toxicity testing has moved towards the earlier stages of drug discovery, in order to identify genotoxic liabilities of new compounds in the pipeline, The Ames MPF 1535 Assay provides novel mutagenicity testing in liquid microplate format, utilizing S. typhimurium TA1535.
The Ames MPF 1537™ Assay As genetic toxicity testing has moved towards the earlier stages of drug discovery, in order to identify genotoxic liabilities of new compounds in the pipeline, The Ames MPF 1537 Assay provides novel mutagenicity testing in liquid microplate format, utilizing S. typhimurium TA1537.
The Ames II™
Mutagenicity Assay, in liquid micro plate format, is a modification of the traditional Ames Plate Incorporation Assay and the Mini-Ames test. The Ames II test reduces hands-on time and also uses much less of the test compound than the regular Ames or Mini-Ames tests.
Microplate format
Ready-to-use reagents
Less hands-on time
Significantly lower amount of test compound
Automatable for high throughput screening
Six fold less plastic ware, reduced disposal costs
For the determination of cytotoxicity in high throughput screenings. The test kits are utilized to determine protein synthesis, membrane permeability, and respiratory or lysosomial activity.
Complete range of Cytoxicity markers
Single and multiple parameters from 1 cellular sample
High throughput screening methods
Easy handling, less hands-on time
Reduced amount of test compound and cells with the multiple parameter test kits
